Headquartered in Parma, Italy, Chiesi Farmaceutici is an international research-oriented biopharmaceuticals group with over 85 years’ experience in the pharmaceutical sector with 31 affiliates, employing over 7,000 people. Chiesi develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. As a certified B Corp since 2019, Chiesi is part of a global community of businesses that meet high standards of social and environmental impact. The company aims to reach Net-Zero greenhouse gases (GHG) emissions by 2035. The Group’s research and development centre in Parma works alongside six other important R&D hubs in France, the US, Canada, China, the UK, and Sweden. Chiesi Limited is headquartered in Manchester and employs over 400 people.

Further information: www.chiesi.uk.com